Aktie 301130 JILIN PROVINCE XIDIAN PHARMACEUTICAL SCI-TECH DEVELOPMENT CO.,LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd

Aktien

301130

CNE1000058C4

301130

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 08.05.2024 		% 5 Tage % 1. Jan.
26,9 CNY +2,48 % Intraday Chart für Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd +6,58 % -3,52 %
22.04. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
29.02. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SZSE:301130) beginnt im Rahmen der am 23. Februar 2024 erteilten Ermächtigung mit einem Aktienrückkaufprogramm im Wert von 100 Millionen CNY. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd's Equity Buyback Plan announced on February 29, 2024.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd commences an Equity Buyback Plan for CNY 100 million worth of its shares, under the authorization approved on February 23, 2024.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Approves Executive Appointments
Xidian Pharmaceutical’s Depression Drug Added to Procurement Program
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Approves Cash Dividend for 2022, Payable on June 12, 2023
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Proposes Final Cash Dividend for the Year 2022
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Certain A Shares of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd are subject to a Lock-Up Agreement Ending on 24-FEB-2023.
Xidian Pharma's Shareholder and Party Acting in Concert Plan to Unload Stake
Certain A Shares of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd are subject to a Lock-Up Agreement Ending on 24-JAN-2023.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 30 June 2022
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Approves Cash Dividend for the Year 2021
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Proposes Final Dividend for 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 301130 Aktie
  4. Nachrichten Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
  5. Andere Sprachen